CINECA IRIS Institutional Research Information System

BROGLIO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.929
EU - Europa 6.488
AS - Asia 5.950
SA - Sud America 1.167
OC - Oceania 174
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 6
Totale 23.831
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.560
SG - Singapore 2.082
CN - Cina 1.826
IT - Italia 1.025
DE - Germania 885
BR - Brasile 884
UA - Ucraina 670
IE - Irlanda 664
FR - Francia 589
SE - Svezia 545
KR - Corea 473
GB - Regno Unito 463
FI - Finlandia 448
VN - Vietnam 337
JP - Giappone 253
PL - Polonia 235
AT - Austria 232
CA - Canada 228
IN - India 186
ES - Italia 164
AU - Australia 152
NL - Olanda 128
ID - Indonesia 121
TR - Turchia 120
HK - Hong Kong 116
MX - Messico 106
RU - Federazione Russa 106
AR - Argentina 92
BE - Belgio 68
CL - Cile 60
PH - Filippine 57
TW - Taiwan 46
IL - Israele 42
MY - Malesia 40
PT - Portogallo 40
CO - Colombia 33
CH - Svizzera 31
GR - Grecia 31
BD - Bangladesh 30
HU - Ungheria 29
DK - Danimarca 27
IR - Iran 27
EC - Ecuador 26
PE - Perù 26
ZA - Sudafrica 25
JO - Giordania 24
RO - Romania 24
TH - Thailandia 22
UZ - Uzbekistan 22
IQ - Iraq 21
NZ - Nuova Zelanda 21
SA - Arabia Saudita 20
EG - Egitto 19
MA - Marocco 17
PY - Paraguay 15
NO - Norvegia 14
CZ - Repubblica Ceca 13
PK - Pakistan 13
VE - Venezuela 13
SN - Senegal 12
LB - Libano 11
RS - Serbia 10
UY - Uruguay 10
LT - Lituania 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
QA - Qatar 8
BO - Bolivia 7
CY - Cipro 7
SI - Slovenia 7
TN - Tunisia 7
BG - Bulgaria 6
NP - Nepal 6
EE - Estonia 5
EU - Europa 5
KZ - Kazakistan 5
AL - Albania 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
GT - Guatemala 4
HN - Honduras 4
AN - Antille olandesi 3
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
CV - Capo Verde 3
IS - Islanda 3
KW - Kuwait 3
MK - Macedonia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
DZ - Algeria 2
HR - Croazia 2
Totale 23.790
Salva come PNG Salva come JPEG
Città #
Beijing 1.164
Singapore 1.018
Chandler 885
Santa Clara 653
Dublin 648
Ashburn 471
Houston 453
Jacksonville 367
Villeurbanne 352
Fairfield 288
Redwood City 246
Dearborn 229
Ann Arbor 221
Princeton 214
Medford 213
Vienna 203
Wilmington 199
Columbus 198
Nyköping 188
Warsaw 183
Los Angeles 164
Milan 145
Torino 144
Munich 137
Boston 126
Woodbridge 126
Seattle 120
Buffalo 116
Cambridge 107
Dallas 96
Hefei 95
Seoul 93
Boardman 90
Turin 87
Fremont 83
São Paulo 80
Pisa 70
Toronto 69
Dong Ket 67
Tokyo 67
Ho Chi Minh City 66
Verona 60
Hong Kong 57
Jakarta 57
Shanghai 51
Hanoi 48
New York 43
London 39
Guangzhou 38
Nanjing 38
Norwalk 38
Turku 37
Brussels 35
Bengaluru 33
Amsterdam 31
Lachine 31
Frankfurt am Main 30
Washington 29
Santiago 28
Düsseldorf 27
Istanbul 27
Nuremberg 27
Rome 27
Mountain View 26
Taipei 26
Ankara 25
Helsinki 25
Rio de Janeiro 24
Sydney 24
Falls Church 23
Buenos Aires 22
Melbourne 19
San Diego 19
The Dalles 19
Detroit 18
Lima 18
Montreal 18
Moscow 18
Redondo Beach 18
Berlin 17
Curitiba 17
Kuala Lumpur 17
Menlo Park 17
San Mateo 17
Atlanta 16
Cupertino 16
Duncan 16
Jinan 16
Zhengzhou 16
Brooklyn 15
Central District 15
Hangzhou 15
Ottawa 15
Phoenix 15
Wuhan 15
Chicago 14
Izmir 14
Mumbai 14
Philadelphia 14
Absecon 13
Totale 12.038
Salva come PNG Salva come JPEG
Nome #
Is the timing of caloric intake associated with variation in diet-induced thermogenesis and in the metabolic pattern? A randomized cross-over study 2.696
Timing of food intake: sounding the alarm about metabolic impairments? A systematic review. 1.554
Effects of Self-Conditioning Techniques (Self-Hypnosis) in Promoting Weight Loss in Patients with Severe Obesity: A Randomized Controlled Trial 637
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 521
Effects of Self-Conditioning Techniques (Self-Hypnosis) in Promoting Weight Loss in Patients with Severe Obesity: A Randomized Controlled Trial 453
Impact of short-term treatment with benzodiazepines and imidazopyridines on glucose metabolism in healthy subjects. 359
Impaired taste sensation in type 2 diabetic patients without chronic complications: a case-control study 346
Ghrelin 254
Changes in the gut microbiota composition during pregnancy in patients with gestational diabetes mellitus (GDM) 241
Acute effects of acylated ghrelin on salbutamol-induced metabolic actions in humans 237
Predictive role of the Mediterranean diet on mortality in individuals at low cardiovascular risk: A 12-year follow-up population-based cohort study 232
Effects of meal timing on changes in circulating epinephrine, norepinephrine, and acylated ghrelin concentrations: A pilot study 200
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase 200
Changes in weight and nutritional habits in adults with obesity during the “lockdown” period caused by the COVID-19 virus emergency 197
The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. 196
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-up 195
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 164
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy 154
Dietary interventions modify the gut microbiota during pregnancy in patients with gestational diabetes mellitus (GDM) 146
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans 139
Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans 138
Acetylcholine regulates ghrelin secretion in humans 137
ACTIVITY OF GH/IGF-I AXIS IN PATIENTS WITH DILATED CARDIOMYOPATHY 130
Circulating ghrelin levels in newborns are not associated to gender, body weight and hormonal parameters but depend on the type of delivery. 127
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION 123
Ghrelin: endocrine, metabolic and cardiovascular actions 123
Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans 122
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma 122
Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences 122
The nutritional status has no major role in the age-related reduction of IGF-I secretion. 122
Endocrine and metabolic response to extreme altitude and physical exercise in athletes. 122
A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score 122
Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. 121
The metabolic response to the activation ofthe beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin 120
Cardiac effects of hexarelin in hypopituitary adults. 119
GHRELIN SECRETION IS INHIBITED BY GLUCOSE LOAD AND INSULIN-INDUCED HYPOGLYCEMIA BUT UNAFFECTED BY GLUCAGON AND ARGININE IN HUMANS 119
Biologic activities of growth hormone secretagogues in humans. 118
Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. 116
Primary hyperparathyroidism is associated with an impaired secretion of growth hormone but not of the other anterior pituitary hormones. 116
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome 116
Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis 115
Activity of GH/IGF-I axis in burn patients: comparison with normal subjects and patients with growth hormone deficiency. 114
Ghrelin: much more than a natural growth hormone secretagogue. 114
Ghrelin inhibits LH pulsatile secretion in humans. 114
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy 114
Is HDL cholesterol protective in patients with type 2 diabetes? A retrospective population-based cohort study 114
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. 113
Testing pituitary function in aging individuals 113
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. 112
Circulating obestatin levels in normal and Type 2 diabetic subjects. 111
The GH response to GHRH in normal adults is not affected by enalapril or furosemide while is blunted by digoxin. 109
Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors 109
MEDIATORI CENTRALI E PERIFERICI DEL COMPORTAMENTO ALIMENTARE 108
Age-related variations of the GH response to GH secretagogues in humans. 106
Presence of cortistatin in the human pancreas. 106
Sleep abnormalities in type 2 diabetes may be associated with glycemic control 106
Beta-adrenergic agonism does not impair the GH response to acylated ghrelin inhumans 106
Self-reported adherence to diet and preferences towards type of meal plan in patient with type 2 diabetes mellitus. A cross-sectional study. 103
Brain-gut communication: cortistatin, somatostatin and ghrelin 102
In Patients with Obesity, Are Affective Temperaments Associated with Attrition? An Evaluation during and before the SARS-CoV-2 Pandemic 102
Continuous glucose monitoring is more effective than mixed meal test in the diagnosis of post-gastric bypass reactive hypoglycemia 101
GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy. 100
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE 100
Endocrine and metabolic actions of ghrelin 100
Other than Growth Hormone Neuroendocrine Actions of Ghrelin 100
Type 2 diabetes mellitus is associated with disruptions as a function of metabolic control. 99
CORTICOTROPH AND ADRENAL RESPONSIVENESS TO hCRH, HEXARELIN AND ACTH IN YOUNG AND ELDERLY SUBJECTS 99
Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers. 99
d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans 99
Affective temperaments and obesity: Is there an association with binge eating episodes and multiple weight cycling? 99
The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans 98
AZIONI ENDOCRINE E EXTRA-ENDOCRINE DI GHRELIN E DEI GHS SINTETICI 98
WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY 98
EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. 97
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? 95
Cardiac effects of hexarelin in hypopituitary adults 95
Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults. 93
Myocardial Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Gene Expression in Failing Hearts Harvested From Patients Undergoing Cardiac Transplantation 93
METABOLIC MODULATION OF GHRELIN SECRETION IN HUMANS 93
Ghrelin and anterior pituitary function 91
Continuous glucose monitoring is more effective than mixed meal test in the diagnosis of post-gastric by pass reactive hypoglycemia 91
CARDIOVASCULAR ACTIVITIES OF NATURAL AND SYNTHETIC GH SECRETAGOGUES 90
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. 90
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans 88
Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy. 88
Ormoni dell’ipofisi posteriore 88
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE 88
Acute Transient Hyperglycemia After Steroid Induction at Transplant Strongly Predicts New-Onset Diabetes and Recurrence of Diabetic Nephropathy 87
Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity 86
Ghrelin and synthetic GH secretagogues. 86
Ghrelin exerts an inhibitory modulation on LH pulsatility in humans. 86
GH secretion is impaired in patients with primary hyperparathyroidism. 85
Pre-operative micronutrient deficiencies in patients with severe obesity candidates for bariatric surgery 85
Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. 84
LH pulsatility is inhibited by ghrelin administration in humans. 84
Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans 83
Endocrine activities of alexamorelin (Ala-His-d-2-methyl-Trp-Ala-Trp-d-Phe-Lys-NH2), a synthetic GH secretagogue, in humans 83
Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations 83
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. 82
Known and unknown growth hormone secretagogue receptors and their ligands 82
Totale 17.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.955
article - articoli 0
book - libri 0
conference - conferenze 5.989
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.721 0 0 0 0 278 121 231 121 288 297 148 237
2021/20222.066 77 100 119 125 146 114 147 120 84 189 338 507
2022/20232.990 335 226 54 276 288 734 276 229 277 69 135 91
2023/20241.341 174 233 98 85 91 129 59 75 23 69 118 187
2024/20254.138 72 319 159 396 970 198 126 196 458 253 394 597
2025/20263.166 769 350 538 1.025 484 0 0 0 0 0 0 0
Totale 24.459